Literature DB >> 7895837

Plasmodium falciparum: effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites.

P J Rosenthal1.   

Abstract

The effects of peptide proteinase inhibitors on globin hydrolysis by cultured malaria parasites were studied. All of the four cysteine proteinase inhibitors evaluated blocked globin hydrolysis, as documented by the development of a morphological abnormality in which parasite food vacuoles filled with undegraded globin and by SDS-PAGE showing that the cysteine proteinase inhibitor-treated parasites accumulated large quantities of globin. The aspartic proteinase inhibitor pepstatin did not block globin hydrolysis by cultured parasites. None of seven antimalarial drugs tested elicited the food vacuole abnormality caused by cysteine proteinase inhibitors, indicating that this morphological alteration was not simply a sign of nonspecific parasite toxicity. Our results indicate that a trophozoite cysteine proteinase is required for initial cleavages of globin by intact malaria parasites.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7895837     DOI: 10.1006/expr.1995.1033

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  27 in total

1.  Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum.

Authors:  L Wang; C G Black; V M Marshall; R L Coppel
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria.

Authors:  Katherine T Andrews; David P Fairlie; Praveen K Madala; John Ray; David M Wyatt; Petrina M Hilton; Lewis A Melville; Lynette Beattie; Donald L Gardiner; Robert C Reid; Martin J Stoermer; Tina Skinner-Adams; Colin Berry; James S McCarthy
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Antimalarial synergy of cysteine and aspartic protease inhibitors.

Authors:  A Semenov; J E Olson; P J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

4.  Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors.

Authors:  P J Rosenthal; J E Olson; G K Lee; J T Palmer; J L Klaus; D Rasnick
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

5.  Non-canonical maturation of two papain-family proteases in Toxoplasma gondii.

Authors:  Zhicheng Dou; Isabelle Coppens; Vern B Carruthers
Journal:  J Biol Chem       Date:  2012-12-18       Impact factor: 5.157

Review 6.  Cathepsin proteases in Toxoplasma gondii.

Authors:  Zhicheng Dou; Vern B Carruthers
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

Review 7.  Malarial hemozoin: from target to tool.

Authors:  Lorena M Coronado; Christopher T Nadovich; Carmenza Spadafora
Journal:  Biochim Biophys Acta       Date:  2014-02-17

8.  Synthesis, Structure-Activity Relationship, and Antimalarial Efficacy of 6-Chloro-2-arylvinylquinolines.

Authors:  Guang Huang; Claribel Murillo Solano; Joel Melendez; Justin Shaw; Jennifer Collins; Robert Banks; Arash Keshavarzi Arshadi; Rachasak Boonhok; Hui Min; Jun Miao; Debopam Chakrabarti; Yu Yuan
Journal:  J Med Chem       Date:  2020-10-06       Impact factor: 7.446

9.  Apical surface expression of aspartic protease Plasmepsin 4, a potential transmission-blocking target of the plasmodium ookinete.

Authors:  Fengwu Li; Kailash P Patra; Charles A Yowell; John B Dame; Karen Chin; Joseph M Vinetz
Journal:  J Biol Chem       Date:  2010-01-07       Impact factor: 5.157

10.  Antimalarial evaluation of copper(II) nanohybrid solids: inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum.

Authors:  Subash Chandra Mohapatra; Hemandra Kumar Tiwari; Manisha Singla; Brijesh Rathi; Arun Sharma; Kuldeep Mahiya; Mukesh Kumar; Saket Sinha; Shyam Singh Chauhan
Journal:  J Biol Inorg Chem       Date:  2009-11-28       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.